Shashank M Dravid Selected Research

Chronic Pain

12/2023	Intravenous recombinant cerebellin 1 treatment restores signalling by spinal glutamate delta 1 receptors and mitigates chronic pain.
10/2021	Dysfunction of Glutamate Delta-1 Receptor-Cerebellin 1 Trans-Synaptic Signaling in the Central Amygdala in Chronic Pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shashank M Dravid Research Topics

Disease

6	Schizophrenia (Dementia Praecox) 01/2023 - 10/2017
3	Pain (Aches) 12/2023 - 05/2011
2	Neuralgia (Stump Neuralgia) 12/2023 - 10/2021
2	Chronic Pain 12/2023 - 10/2021
2	Autistic Disorder (Autism) 01/2021 - 01/2016
1	Demyelinating Diseases (Demyelinating Disease) 01/2023
1	Inflammation (Inflammations) 01/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Epilepsy (Aura) 12/2021
1	Anxiety Disorders (Anxiety Disorder) 11/2021
1	Mental Disorders (Mental Disorder) 01/2021
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2021
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2020
1	Viremia 01/2020
1	Seizures (Absence Seizure) 01/2019
1	Encephalitis (Encephalitis, Rasmussen) 01/2019
1	Memory Disorders (Memory Loss) 01/2019
1	Autoimmune Diseases of the Nervous System 01/2019
1	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2019
1	Cognitive Dysfunction 12/2016
1	Neurodevelopmental Disorders 01/2016
1	Ischemia 01/2013
1	Stroke (Strokes) 01/2013

Drug/Important Bio-Agent (IBA)

8	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2021 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2021
3	Glutamic Acid (Glutamate)FDA Link 12/2023 - 10/2021
2	AMPA Receptors (AMPA Receptor)IBA 12/2023 - 10/2021
2	cerebellinIBA 12/2023 - 10/2021
2	ParvalbuminsIBA 01/2023 - 01/2018
1	Freund's AdjuvantIBA 12/2023
1	Analgesics (Analgesic Drugs)IBA 12/2023
1	CuprizoneIBA 01/2023
1	InflammasomesIBA 01/2022
1	Neuroprotective AgentsIBA 12/2021
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 11/2021
1	Cycloserine (Seromycin)FDA Link 11/2021
1	N-Methylaspartate (NMDA)IBA 11/2021
1	Antipsychotic Agents (Antipsychotics)IBA 01/2020
1	Trans-Activators (Trans-Acting Factor)IBA 01/2020
1	tat Gene Products (tat Protein)IBA 01/2020
1	Dizocilpine Maleate (Dizocilpine)IBA 01/2020
1	Apomorphine FDA Link 01/2020
1	Midazolam (Versed)FDA LinkGeneric 01/2020
1	AlbuminsIBA 01/2019
1	AntibodiesIBA 01/2019
1	AutoantibodiesIBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	ifenprodilIBA 01/2013
1	GalactosidasesIBA 05/2011

Therapy/Procedure

4	Therapeutics 12/2023 - 01/2019
1	Intravenous Injections 12/2023
1	Intraventricular Infusions 01/2019